Tag: 10kHz therapy

Nevro to highlight 25 scientific abstracts on spinal cord stimulation at...

Nevro Corporation has announced a series of data presentations supporting the use of the company's high-frequency (HFX) 10kHz spinal cord stimulation (SCS) therapy for...

Nevro announces new data demonstrating health economic benefits of 10kHz SCS...

Nevro Corporation has announced the publication of new data validating the health economic benefits of 10kHz therapy, the company’s proprietary, high-frequency spinal cord stimulation...

Nevro announces two late-breaking data presentations set for NANS 2023

Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP) treatments have been...
senza-pdn study

NANS 2022: New 18-month data show durability of high-frequency SCS for...

This year’s North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA) saw 18-month data from SENZA-PDN—a randomised controlled trial (RCT) evaluating the...

Nevro announces clinical data reinforcing significant and durable benefits of 10kHz...

Nevro Corporation has announced the results from data presentations at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA) supporting...